• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子-α和白细胞介素-10基因多态性对异基因造血干细胞移植后移植物抗宿主病的影响

Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation.

作者信息

Takahashi H, Furukawa T, Hashimoto S, Suzuki N, Kuroha T, Yamazaki F, Inano K, Takahashi M, Aizawa Y, Koike T

机构信息

First Department of Internal Medicine, College of Biochemical Technology, Niigata University School of Medicine, Japan.

出版信息

Bone Marrow Transplant. 2000 Dec;26(12):1317-23. doi: 10.1038/sj.bmt.1702724.

DOI:10.1038/sj.bmt.1702724
PMID:11223972
Abstract

Some cytokines are believed to play a role in the development of acute and chronic GVHD after allo-hematopoietic stem cell transplantation. It has been reported that TNF-alpha and IL-10 gene polymorphisms are associated with the production of those cytokines and the development of graft failure after organ transplantation and systemic lupus erythematosus. We examined whether TNF-alpha and IL-10 gene polymorphisms affect the severity of acute GVHD (aGVHD) and chronic GVHD (cGVHD). Sixty-two and 54 patients were available for the analysis of aGVHD and cGVHD, respectively. We analyzed the gene polymorphisms derived from pre- and post-transplant blood cells. Donor-derived TNF2 allele (A) was more frequently detected in patients with aGVHD III/IV than those aGVHD 0-II (2/6 vs 2/56) (P = 0.04). The donors of the patients with cGVHD more frequently possessed a greater number of alleles (allele 13 or more which contain 26 or more CA repeats) in IL-10.G than those without (13/26 vs 5/28) (P = 0.02), and the patients with cGVHD had more CA repeats in donor-derived IL-10.G than those without (mean = 25.2 vs 23.4) (P = 0.01). Donor-derived TNF-308 and IL-10.G alleles may contribute to severe aGVHD and cGVHD, respectively, and will help us distinguish those patients at high risk for GVHD.

摘要

一些细胞因子被认为在异基因造血干细胞移植后的急性和慢性移植物抗宿主病(GVHD)发展中起作用。据报道,肿瘤坏死因子-α(TNF-α)和白细胞介素-10(IL-10)基因多态性与这些细胞因子的产生以及器官移植和系统性红斑狼疮后移植物失败的发展有关。我们研究了TNF-α和IL-10基因多态性是否会影响急性移植物抗宿主病(aGVHD)和慢性移植物抗宿主病(cGVHD)的严重程度。分别有62例和54例患者可用于aGVHD和cGVHD的分析。我们分析了移植前后血细胞的基因多态性。与aGVHD 0-II级患者相比,aGVHD III/IV级患者中更频繁地检测到供体来源的TNF2等位基因(A)(2/6 vs 2/56)(P = 0.04)。cGVHD患者的供体在IL-10.G中比无cGVHD的供体更频繁地拥有更多数量的等位基因(等位基因13个或更多,其中包含26个或更多CA重复序列)(13/26 vs 5/28)(P = 0.02),并且cGVHD患者供体来源的IL-10.G中的CA重复序列比无cGVHD的患者更多(平均值 = 25.2 vs 23.4)(P = 0.01)。供体来源的TNF - 308和IL-10.G等位基因可能分别导致严重的aGVHD和cGVHD,并将有助于我们区分那些GVHD高风险患者。

相似文献

1
Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation.肿瘤坏死因子-α和白细胞介素-10基因多态性对异基因造血干细胞移植后移植物抗宿主病的影响
Bone Marrow Transplant. 2000 Dec;26(12):1317-23. doi: 10.1038/sj.bmt.1702724.
2
Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.肿瘤坏死因子-α基因多态性与儿童异基因骨髓移植后急性移植物抗宿主病严重程度相关:儿科血液和骨髓移植联盟研究。
Biol Blood Marrow Transplant. 2010 Jul;16(7):927-936.e1. doi: 10.1016/j.bbmt.2010.01.009. Epub 2010 Jan 25.
3
IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.异基因同胞造血干细胞移植患者及供者的白细胞介素-6和白细胞介素-10启动子基因多态性与急性移植物抗宿主病风险相关。
Hum Immunol. 2005 Jun;66(6):700-10. doi: 10.1016/j.humimm.2005.02.003. Epub 2005 Mar 19.
4
IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.白细胞介素2和肿瘤坏死因子α基因多态性与异基因造血干细胞移植后移植物抗宿主病的风险
Scand J Immunol. 2007 Dec;66(6):703-10. doi: 10.1111/j.1365-3083.2007.02021.x.
5
Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.对异基因干细胞移植后有急性移植物抗宿主病病史的患者队列中预测进展型或静止型慢性移植物抗宿主病的危险因素分析。
Bone Marrow Transplant. 2006 Apr;37(7):699-708. doi: 10.1038/sj.bmt.1705313.
6
Polymorphisms within the genes encoding TNF-alpha and TNF-beta associate with the incidence of post-transplant complications in recipients of allogeneic hematopoietic stem cell transplants.编码肿瘤坏死因子-α(TNF-α)和肿瘤坏死因子-β(TNF-β)的基因内多态性与同种异体造血干细胞移植受者移植后并发症的发生率相关。
Arch Immunol Ther Exp (Warsz). 2004 Jul-Aug;52(4):240-9.
7
Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.白细胞介素-18和可溶性白细胞介素2受体对部分伊朗患者造血干细胞移植后急性移植物抗宿主病发生情况的影响
Transpl Immunol. 2006 Jan;15(3):223-7. doi: 10.1016/j.trim.2005.10.002. Epub 2005 Nov 28.
8
Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.在急性髓系白血病患者接受不匹配、非亲属造血干细胞移植后,使用低剂量抗胸腺细胞球蛋白成功预防急性移植物抗宿主病。
Biol Blood Marrow Transplant. 2009 Jun;15(6):704-17. doi: 10.1016/j.bbmt.2009.02.010. Epub 2009 Apr 9.
9
[Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].[难治性或复发性急性白血病异基因造血干细胞移植后急性移植物抗宿主病的诱导]
Ai Zheng. 2003 Dec;22(12):1321-4.
10
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.

引用本文的文献

1
Association Between Human Leukocyte Antigens and Graft-Versus-Host Disease Occurrence in Allogeneic Hematopoietic Stem Cell Transplantation - A 10-Year Experience on Iranian Patients.同种异体造血干细胞移植中人类白细胞抗原与移植物抗宿主病发生的关系:伊朗患者 10 年经验。
Arch Iran Med. 2022 Dec 1;25(12):798-806. doi: 10.34172/aim.2022.125.
2
Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.遗传变异作为异基因造血干细胞移植后慢性移植物抗宿主病的预测性生物标志物的研究进展。
Front Immunol. 2020 Oct 19;11:575492. doi: 10.3389/fimmu.2020.575492. eCollection 2020.
3
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.
美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:III. 2014年生物标志物工作组报告。
Biol Blood Marrow Transplant. 2015 May;21(5):780-92. doi: 10.1016/j.bbmt.2015.01.003. Epub 2015 Jan 30.
4
Role of non-HLA gene polymorphisms in graft-versus-host disease.非 HLA 基因多态性在移植物抗宿主病中的作用。
Int J Hematol. 2013 Sep;98(3):309-18. doi: 10.1007/s12185-013-1416-7. Epub 2013 Aug 15.
5
The major histocompatibility complex: a model for understanding graft-versus-host disease.主要组织相容性复合体:理解移植物抗宿主病的模型。
Blood. 2013 Sep 12;122(11):1863-72. doi: 10.1182/blood-2013-05-355982. Epub 2013 Jul 22.
6
Biologic markers of chronic GVHD.慢性移植物抗宿主病的生物学标志物
Bone Marrow Transplant. 2014 Mar;49(3):324-31. doi: 10.1038/bmt.2013.97. Epub 2013 Jul 22.
7
Genetics of graft-versus-host disease: the major histocompatibility complex.移植物抗宿主病的遗传学:主要组织相容性复合体。
Blood Rev. 2013 Jan;27(1):1-12. doi: 10.1016/j.blre.2012.10.001. Epub 2012 Nov 20.
8
Evaluation of published single nucleotide polymorphisms associated with acute GVHD.评估与急性移植物抗宿主病相关的已发表单核苷酸多态性。
Blood. 2012 May 31;119(22):5311-9. doi: 10.1182/blood-2011-09-371153. Epub 2012 Jan 26.
9
Biomarkers in chronic graft-versus-host disease.慢性移植物抗宿主病的生物标志物。
Expert Rev Hematol. 2011 Jun;4(3):329-42. doi: 10.1586/ehm.11.27.
10
Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.定义异基因造血干细胞移植后移植物抗宿主病和死亡率的遗传风险。
Curr Opin Hematol. 2010 Nov;17(6):483-92. doi: 10.1097/MOH.0b013e32833eb770.